loading
전일 마감가:
$56.34
열려 있는:
$56.35
하루 거래량:
861.59K
Relative Volume:
0.28
시가총액:
$4.80B
수익:
$170.10M
순이익/손실:
$-239.59M
주가수익비율:
-19.80
EPS:
-2.8
순현금흐름:
$-191.20M
1주 성능:
-1.19%
1개월 성능:
+8.60%
6개월 성능:
+39.99%
1년 성능:
+17.60%
1일 변동 폭
Value
$54.84
$56.80
1주일 범위
Value
$52.50
$59.89
52주 변동 폭
Value
$30.04
$71.13

크리스퍼 테라퓨틱스 Stock (CRSP) Company Profile

Name
명칭
Crispr Therapeutics Ag
Name
전화
(617) 315-4600
Name
주소
BAARERSTRASSE 14, ZUG
Name
직원
393
Name
트위터
@crisprtx
Name
다음 수익 날짜
2024-12-05
Name
최신 SEC 제출 서류
Name
CRSP's Discussions on Twitter

CRSP을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CRSP
Crispr Therapeutics Ag
55.62 5.06B 170.10M -239.59M -191.20M -2.80
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
385.97 96.11B 11.42B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.30 60.40B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
430.84 54.91B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
672.75 41.30B 3.05B 1.28B -614.78M 19.58
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.34 33.25B 3.81B -644.79M -669.77M -6.24

크리스퍼 테라퓨틱스 Stock (CRSP) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-02-14 업그레이드 Evercore ISI In-line → Outperform
2025-02-12 업그레이드 TD Cowen Sell → Hold
2025-02-03 개시 H.C. Wainwright Buy
2024-08-06 재확인 Needham Buy
2024-08-02 개시 Rodman & Renshaw Buy
2024-06-28 재개 Guggenheim Neutral
2024-02-15 개시 Wolfe Research Peer Perform
2023-12-11 다운그레이드 TD Cowen Market Perform → Underperform
2023-10-17 다운그레이드 Cantor Fitzgerald Overweight → Neutral
2023-09-27 개시 Mizuho Buy
2023-08-17 업그레이드 Citigroup Neutral → Buy
2023-05-30 개시 William Blair Outperform
2023-04-13 개시 Cantor Fitzgerald Overweight
2023-03-21 개시 Bernstein Mkt Perform
2023-03-17 개시 Bryan Garnier Buy
2023-03-07 개시 Robert W. Baird Neutral
2022-10-11 개시 Morgan Stanley Underweight
2022-08-09 다운그레이드 Barclays Overweight → Equal Weight
2022-06-23 다운그레이드 Evercore ISI Outperform → In-line
2022-06-17 개시 BMO Capital Markets Outperform
2022-04-28 개시 Credit Suisse Neutral
2021-12-07 개시 Cowen Market Perform
2021-10-19 개시 SVB Leerink Outperform
2021-06-14 업그레이드 Citigroup Sell → Neutral
2021-04-21 업그레이드 Jefferies Hold → Buy
2021-03-04 개시 JMP Securities Mkt Outperform
2020-12-10 재확인 Chardan Capital Markets Buy
2020-12-10 다운그레이드 Jefferies Buy → Hold
2020-12-10 재확인 Needham Buy
2020-12-07 다운그레이드 Wells Fargo Overweight → Equal Weight
2020-10-23 개시 RBC Capital Mkts Sector Perform
2020-10-05 개시 BofA Securities Buy
2020-07-28 재확인 Needham Buy
2020-07-14 개시 SunTrust Buy
2020-06-15 재확인 Canaccord Genuity Buy
2020-03-05 개시 Stifel Hold
2020-02-03 다운그레이드 Evercore ISI Outperform → In-line
2019-11-19 업그레이드 William Blair Mkt Perform → Outperform
2019-11-12 업그레이드 Oppenheimer Perform → Outperform
2019-08-01 개시 Jefferies Buy
2019-07-26 개시 Canaccord Genuity Buy
2019-06-10 개시 ROTH Capital Buy
2019-04-12 개시 Evercore ISI Outperform
2019-03-14 개시 William Blair Mkt Perform
2019-01-28 다운그레이드 Goldman Buy → Neutral
2019-01-22 다운그레이드 Citigroup Neutral → Sell
모두보기

크리스퍼 테라퓨틱스 주식(CRSP)의 최신 뉴스

pulisher
09:19 AM

Brookline Capital Management Estimates CRSP Q3 Earnings - MarketBeat

09:19 AM
pulisher
09:10 AM

Leerink Partnrs Has Pessimistic View of CRSP Q3 Earnings - MarketBeat

09:10 AM
pulisher
08:40 AM

Crispr Therapeutics AG: Strong Sales Growth and Global Expansion Justify Buy Rating - TipRanks

08:40 AM
pulisher
08:33 AM

FY2027 Earnings Estimate for CRSP Issued By Leerink Partnrs - MarketBeat

08:33 AM
pulisher
08:29 AM

HC Wainwright Raises CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $80.00 - MarketBeat

08:29 AM
pulisher
08:22 AM

CRISPR Therapeutics stock price target raised to $80 by H.C. Wainwright - Investing.com Nigeria

08:22 AM
pulisher
06:38 AM

Banque Cantonale Vaudoise Makes New Investment in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

06:38 AM
pulisher
03:07 AM

Privium Fund Management B.V. Acquires 25,100 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

03:07 AM
pulisher
Aug 06, 2025

CRISPR Therapeutics' (CRSP) "Buy" Rating Reiterated at Chardan Capital - MarketBeat

Aug 06, 2025
pulisher
Aug 06, 2025

CRISPR Therapeutics (NASDAQ:CRSP) Issues Quarterly Earnings Results, Beats Expectations By $0.18 EPS - MarketBeat

Aug 06, 2025
pulisher
Aug 05, 2025

CRISPR Therapeutics (NASDAQ:CRSP) Shares Gap DownShould You Sell? - MarketBeat

Aug 05, 2025
pulisher
Aug 05, 2025

CRSP Stock Down on Huge Q2 Loss, Focus on Increasing Casgevy Adoption - Zacks Investment Research

Aug 05, 2025
pulisher
Aug 05, 2025

CRISPR Therapeutics (NASDAQ:CRSP) Price Target Raised to $42.00 at Royal Bank Of Canada - MarketBeat

Aug 05, 2025
pulisher
Aug 05, 2025

Up 50% in 3 Months, Is This Stock Still a Buy? - The Motley Fool

Aug 05, 2025
pulisher
Aug 05, 2025

Crispr Therapeutics AG: Strong Financial Foundation and Promising Pipeline Amidst Strategic Growth - TipRanks

Aug 05, 2025
pulisher
Aug 05, 2025

IQ EQ FUND MANAGEMENT IRELAND Ltd Has $2.22 Million Stake in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Aug 05, 2025
pulisher
Aug 05, 2025

Crispr Therapeutics AG: Promising Growth and Expanding Pipeline Justify Buy Rating - TipRanks

Aug 05, 2025
pulisher
Aug 05, 2025

Bayforest Capital Ltd Purchases Shares of 12,424 CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Aug 05, 2025
pulisher
Aug 04, 2025

CRISPR Therapeutics AG (CRSP) Reports Q2 Loss, Lags Revenue Estimates - MSN

Aug 04, 2025
pulisher
Aug 04, 2025

CRISPR Therapeutics AG reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 04, 2025
pulisher
Aug 04, 2025

Crispr Therapeutics shares tumble after significant earnings miss By Investing.com - Investing.com Nigeria

Aug 04, 2025
pulisher
Aug 04, 2025

Crispr Therapeutics shares tumble after significant earnings miss - Investing.com

Aug 04, 2025
pulisher
Aug 04, 2025

Crispr Therapeutics earnings missed by $1.00, revenue fell short of estimates - Investing.com

Aug 04, 2025
pulisher
Aug 04, 2025

CRISPR Therapeutics AG SEC 10-Q Report - TradingView

Aug 04, 2025
pulisher
Aug 04, 2025

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results - GlobeNewswire

Aug 04, 2025
pulisher
Aug 03, 2025

Published on: 2025-08-04 01:34:11 - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What analysts say about CRISPR Therapeutics AG stockCapitalize on market trends with confidence - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are CRISPR Therapeutics AG company’s key revenue driversCapitalize on fast-moving stock trends - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are the latest earnings results for CRISPR Therapeutics AGMaximize gains with data-driven stock picks - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is Zacks Research's Estimate for CRSP Q2 Earnings? - MarketBeat

Aug 03, 2025
pulisher
Aug 03, 2025

When is CRISPR Therapeutics AG stock expected to show significant growthFree Trading Strategy Suggestions - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What drives CRISPR Therapeutics AG stock priceAchieve consistent double-digit growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

Published on: 2025-08-03 05:26:58 - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

CRISPR Therapeutics (CRSP) Sees 47% Price Increase Over Last Quarter - simplywall.st

Aug 02, 2025
pulisher
Aug 02, 2025

CRISPR Therapeutics AG (CRSP) Sees a More Significant Dip Than Broader Market: Some Facts to Know - MSN

Aug 02, 2025
pulisher
Aug 02, 2025

Cerity Partners LLC Invests $216,000 in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Aug 02, 2025
pulisher
Aug 02, 2025

CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 4.1%Here's What Happened - MarketBeat

Aug 02, 2025
pulisher
Aug 01, 2025

Is CRISPR Therapeutics AG a growth stock or a value stockAdvanced Screener Ideas For Every Investor - Jammu Links News

Aug 01, 2025
pulisher
Aug 01, 2025

Inspire Advisors LLC Invests $459,000 in CRISPR Therapeutics AG (NASDAQ:CRSP) - MarketBeat

Aug 01, 2025
pulisher
Aug 01, 2025

Crispr Therapeutics shares rise 1.18% after-hours following Intellia Therapeutics' inducement grants announcement. - AInvest

Aug 01, 2025
pulisher
Jul 31, 2025

How volatile is CRISPR Therapeutics AG stock compared to the marketAI Powered Review For 2025 - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

Is CRISPR Therapeutics AG stock overvalued or undervaluedStock Strategy Signals For Smart Trading - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 30, 2025

Published on: 2025-07-30 00:12:31 - beatles.ru

Jul 30, 2025
pulisher
Jul 30, 2025

Should You Invest in CRISPR Therapeutics (CRSP) Based on Bullish Wall Street Views? - Yahoo Finance

Jul 30, 2025
pulisher
Jul 30, 2025

CRISPR Therapeutics to Report Q2 Earnings: What's in the Cards? - MSN

Jul 30, 2025
pulisher
Jul 30, 2025

CRISPR Therapeutics AG (NASDAQ:CRSP) is ARK Investment Management LLC's 10th Largest Position - MarketBeat

Jul 30, 2025
pulisher
Jul 30, 2025

CRISPR Therapeutics AG (CRSP) May Report Negative Earnings: Know the Trend Ahead of Q2 Release - MSN

Jul 30, 2025

크리스퍼 테라퓨틱스 (CRSP) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$77.30
price down icon 0.43%
$36.80
price down icon 0.82%
$108.59
price down icon 2.21%
$27.91
price down icon 2.14%
$113.33
price up icon 1.83%
biotechnology ONC
$294.82
price down icon 1.17%
자본화:     |  볼륨(24시간):